Vulvar melanoma: A multivariable analysis of 644 patients

Obstetrics and Gynecology

Volumn 110, Issue 2 I, 2007, Pages 296-301

  Sugiyama, Valerie E ^b   Chan, John K ^a   Shin, Jacob Y ^b   Berek, Jonathan S ^b   Osann, Kathryn ^b   Kapp, Daniel S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISPANIC; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; VULVA CANCER; AGE; CANCER REGISTRY; CANCER STAGING; CHILD; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICS; UNITED STATES; VULVA TUMOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; UNITED STATES; VULVAR NEOPLASMS;

EID: 34548463077     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000271209.67461.91     Document Type: Article

References (40)

1. Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. p. 543-84.
2. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664-78.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
4. Morrow CP, DiSaia PJ. Malignant melanoma of the female genitalia: a clinical analysis. Obstet Gynecol Surv 1976;31:233-71.
5. Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlof B, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival. Cancer 1999;86:1285-93.
6. Wechter ME, Gruber SB, Haefner HK, Lowe L, Schwartz JL, Reynolds KR, et al. Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol 2004;50:554-62.
7. U.S. National Institutes of Health. National Cancer Institute. Surveillance epidemiology and end results. Available at: http://seer.cancer.gov/ . Retrieved May 22, 2007.
8. Cancer Statistics Branch, Surveillance Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services. The SEER Program Code Manual. 3rd ed. 1998. Appendix C, p. C-102, and Appendix D, p. D-138. Available at: seer.cancer.gov/manuals/codeman.pdf. Retrieved May 22, 2007.
9. Trimble EL. Melanomas of the vulva and vagina. Oncology (Williston Park) 1996;10:1017-23.
10. Verschraegen CF, Benjapibal M, Supakarapongkul W, Levy LB, Ross M, Atkinson EN, et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer 2001;11:359-64.
11. Raspagliesi F, Ditto A, Paladini D, Fontanelli R, Stefanon B, Dipalma S, et al. Prognostic indicators in melanoma of the vulva. Ann Surg Oncol 2000;7:738-42.
12. Raber G, Mempel V, Jackisch C, Hundeiker M, Heinecke A, Kurzl R, et al. Malignant melanoma of the vulva. Report of 89 patients. Cancer 1996; 78:2353-8.
13. Phillips GL, Bundy BN, Okagaki T, Kucera PR, Stehman FB. Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group. Cancer 1994;73:2626-32.
14. Trimble EL, Lewis JL Jr, Williams LL, Curtin JP, Chapman D, Woodruff JM, et al. Management of vulvar melanoma. Gynecol Oncol 1992;45:254-8.
15. Bradgate MG, Rollason TP, McConkey CC, Powell J. Malignant melanoma of the vulva: a clinicopathological study of 50 women. Br J Obstet Gynaecol 1990;97:124-33.
16. Podratz KC, Gaffey TA, Symmonds RE, Johansen KL, O'Brien PC. Melanoma of the vulva: an update. Gynecol Oncol 1983;16:153-68.
17. Ariel IM. Malignant melanoma of the female genital system: a report of 48 patients and review of the literature. J Surg Oncol 1981;16:371-83.
18. Scheistroen M, Trope C, Kaern J, Abeler VM, Pettersen EO, Kristensen GB. Malignant melanoma of the vulva FIGO stage I: evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment. Gynecol Oncol 1996;61:253-8.
19. Scheistroen M, Trope C, Koern J, Pettersen EO, Abeler VM, Kristensen GB. Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients. Cancer 1995;75:72-80.
20. DeMatos P, Tyler D, Seigler HF. Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery 1998;124:38-48.
21. Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994;171:1225-30.
22. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al, editors. AJCC cancer staging handbook. 6th ed. New York (NY): Springer-Verlag; 2002.
23. Chung AF, Woodruff JM, Lewis JL Jr. Malignant melanoma of the vulva: a report of 44 cases. Obstet Gynecol 1975;45:638-46.
24. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
25. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-27.
26. Jaramillo BA, Ganjei P, Averette HE, Sevin BU, Lovecchio JL. Malignant melanoma of the vulva. Obstet Gynecol 1985;66:398-401.
27. Phillips GL, Twiggs LB, Okagaki T. Vulvar melanoma: a microstaging study. Gynecol Oncol 1982;14:80-8.
28. Tasseron EW, van der Esch EP, Hart AA, Brutel de la Riviere G, Aartsen EJ. A clinicopathological study of 30 melanomas of the vulva. Gynecol Oncol 1992;46:170-5.
29. Johnson TL, Kumar NB, White CD, Morley GW. Prognostic features of vulvar melanoma: a clinicopathologic analysis. Int J Gynecol Pathol 1986;5:110-8.
30. Gimotty PA, Botbyl J, Soong SJ, Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 2005;23:8065-75.
31. Rose PG, Piver MS, Tsukada Y, Lau T. Conservative therapy for melanoma of the vulva. Am J Obstet Gynecol 1988;159:52-5.
32. Morgan MA, Mikuta JJ. Surgical management of vulvar cancer. Semin Surg Oncol 1999;17:168-72.
33. Davidson T, Kissin M, Westbury G. Vulvo-vaginal melanoma-should radical surgery be abandoned? Br J Obstet Gynaecol 1987;94:473-6.
34. Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suciu S. Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. Cancer Treat Rev 2003;29:241-52.
35. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 1986;12:867-72.
36. Ballo MT, Ang KK. Radiation therapy for malignant melanoma. Surg Clin North Am 2003;83:323-42.
37. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68:733-40.
38. Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol 2006;103:1095-9.
39. Rosenberg SA, Packard BS, Aebersold PM, et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med 1988;319:1676-80.
40. Kim CJ, Dessureault S, Gabrilovich D, Reintgen DS, Slingluff CL Jr. Immunotherapy for melanoma. Cancer Control 2002;9:22-30.